NCT01621542 Clinical Study of WT2725 in Patients With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT01611623 Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Solid Tumor Malignancies Status COMPLETED Phase PHASE1
NCT01605643 Biomarker Feedback to Motivate Tobacco Cessation in Pregnant Alaska Native Women Status COMPLETED Phase N/A
NCT01604863 A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies Status SUSPENDED Phase PHASE1
NCT01602445 Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism Status COMPLETED Phase N/A
NCT01602432 Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer Patients Status WITHDRAWN Phase N/A
NCT01599143 Identifying Therapeutic Factors in an 8-Week (30 Hour) Mindfulness-Based Stress Reduction (MBSR) Program Status COMPLETED Phase PHASE1
NCT01597284 Oral Therapies in Oncology: Cognitive Function and Compliance Status TERMINATED Phase N/A
NCT01596374 Clinical Relevance of ROS (V-ros UR2 Sarcoma Virus Oncogene Homolog) Aberrations in Solid Tumours Status UNKNOWN Phase N/A
NCT01593085 Evaluation of States in Major Depressive Patients With Cancer, Hospitalized in a Hospital Palliative Status COMPLETED Phase N/A
NCT01591187 The Feasibility of Text Messaging to Assess Secondhand Smoke Exposure Among Youngsters With Cancer or Sickle Cell Disease Status COMPLETED Phase N/A
NCT01590394 Patency of a Prototype Large Plastic Biliary Stent in the Palliation of Malignant Distal Biliary Strictures. Status TERMINATED Phase NA
NCT01589406 Quality of Life and Sexuality in Women With Gynaecological Cancer Status UNKNOWN Phase N/A
NCT01586624 A Phase I Trial of Vandetanib (AZD6474) and Selumetinib (AZD6244) for Solid Tumours Including Non Small Cell Lung Cancer (VanSel-1) Status COMPLETED Phase PHASE1
NCT01586026 Study to Extend the Maximum Maintenance Flushing Interval for Ports With Distally Valved Catheters Status TERMINATED Phase N/A
NCT01582997 A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of of GSK2118436 in Japanese Subjects With BRAF Mutation Positive Solid Tumors Status COMPLETED Phase PHASE1